Ali Bushra, Salim Adnan, Alam Altaf, Zuberi Bader Faiyaz, Ali Zeeshan, Azam Zahid, Kamani Lubna, Farooqi Javed Iqbal, Salih Muhammed, Nawaz Arif Amir, Chaudhry Asad Ali, Hashmi Zahid Yasin, Siddique Masood
Bushra Ali, Fatima Memorial Medical and Dental College, Lahore, Pakistan.
Adnan Salim, Shaikh Zayed Postgraduate Medical Institute, Lahore, Pakistan.
Pak J Med Sci. 2020 Jul-Aug;36(5):1117-1132. doi: 10.12669/pjms.36.5.2407.
Approximately one half of patients develop ascites within 10 years of diagnosis of compensated cirrhosis. It is a poor prognostic indicator, with only 50% surviving beyond two years. Mortality worsens significantly to 20% to 50% at one year if the ascites becomes refractory to medical therapy. Pakistan has one of the highest prevalence of viral hepatitis in the world and patients with ascites secondary to liver cirrhosis make a major percentage of both inpatient and outpatient burden. Studies indicate that over 80% of patients admitted with ascites have liver cirrhosis as the cause. This expert opinion suggests proper assessment of patients with ascites in the presence of underlying cirrhosis. This expert opinion includes appropriate diagnosis and management of uncomplicated ascites, refractory ascites and complicated ascites (including spontaneous bacterial peritonitis (SBP) ascites, hepatorenal syndrome (HRS) and hyponatremia. The purpose behind this expert opinion is to help consultants, postgraduate trainees, medical officers and primary care physicians optimally manage their patients with cirrhosis and ascites in a resource constrained setting as is often encountered in a developing country like Pakistan.
约一半的患者在代偿期肝硬化确诊后的10年内会出现腹水。它是一个预后不良的指标,只有50%的患者能存活超过两年。如果腹水对药物治疗产生耐药,一年的死亡率会显著恶化至20%至50%。巴基斯坦是世界上病毒性肝炎患病率最高的国家之一,肝硬化继发腹水的患者在住院和门诊负担中占很大比例。研究表明,超过80%因腹水入院的患者病因是肝硬化。本专家意见建议对存在潜在肝硬化的腹水患者进行恰当评估。本专家意见包括对单纯性腹水、顽固性腹水和复杂性腹水(包括自发性细菌性腹膜炎(SBP)腹水、肝肾综合征(HRS)和低钠血症)进行适当的诊断和管理。本专家意见的目的是帮助会诊医生、研究生学员、医务人员和初级保健医生,在像巴基斯坦这样的发展中国家经常遇到的资源有限的情况下,对肝硬化和腹水患者进行最佳管理。